Skip to main content

Qiagen N.V.

QGEN
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001015820

No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.

Politicians who traded QGEN

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
4
Filings
3
Politicians
2
Buys / sells
1 / 3
Estimated volume
$32.0K
Sum of range midpoints
Politicians who traded QGEN
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Peter Welch House · VT
21 / 1$16.0KMar 24, 2020Apr 3, 2020
Donna E. Shalala House · FL
20 / 2$16.0KJan 23, 2019Apr 27, 2020

Trades

Reported trades in Qiagen N.V., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Donna E. Shalala House · FL
QGENQiagen N.V. Common SharesSell (partial)SelfJan 23, 2019Apr 27, 2020460 daysLate$1K-$15KFiling
Donna E. Shalala House · FL
QGENQiagen N.V. Common SharesSellSelfJan 9, 2019Apr 27, 2020474 daysLate$1K-$15KFiling
Peter Welch House · VT
QGENQiagen N.V. Common SharesSellSelfMar 24, 2020Apr 3, 202010 days$1K-$15KFiling
Peter Welch House · VT
QGENQiagen N.V. Common SharesBuySelfFeb 27, 2020Mar 10, 202012 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.